GILD logo

GILD
Gilead Sciences, Inc.

77,705
Mkt Cap
$154.02B
Volume
152.00
52W High
$129.39
52W Low
$92.21
PE Ratio
20.00
GILD Fundamentals
Price
$129.11
Prev Close
$124.14
Open
$123.73
50D MA
$123.28
Beta
0.35
Avg. Volume
6.61M
EPS (Annual)
$0.3825
P/B
7.44
Rev/Employee
$1.63M
Loading...
Loading...
News
all
press releases
CapWealth Advisors LLC Lowers Position in Gilead Sciences, Inc. $GILD
CapWealth Advisors LLC trimmed its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 3.7% during the 3rd quarter, according to the company in its most recent 13F filing with...
MarketBeat·1h ago
News Placeholder
More News
News Placeholder
Jeffrey Bluestone Sells 5,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock
Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) Director Jeffrey Bluestone sold 5,000 shares of Gilead Sciences stock in a transaction dated Tuesday, January 20th. The stock was sold at an...
MarketBeat·11h ago
News Placeholder
New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy Plus Keytruda as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative Breast Cancer
Gilead Sciences, Inc. (Nasdaq: GILD) today announced The New England Journal of Medicine (NEJM) published the full results from the positive Phase 3 ASCENT-04/KEYNOTE-D19 study evaluating the...
Business Wire·12h ago
News Placeholder
Gilead Sciences (NASDAQ:GILD) Reaches New 12-Month High After Analyst Upgrade
Gilead Sciences (NASDAQ:GILD) Hits New 52-Week High Following Analyst Upgrade...
MarketBeat·13h ago
News Placeholder
Rothschild & Co Redburn Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price
Rothschild & Co Redburn lifted their price target on shares of Gilead Sciences from $153.00 to $159.00 and gave the stock a "buy" rating in a research report on Tuesday...
MarketBeat·19h ago
News Placeholder
Universal Beteiligungs und Servicegesellschaft mbH Lowers Position in Gilead Sciences, Inc. $GILD
Universal Beteiligungs und Servicegesellschaft mbH lessened its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 4.5% in the 3rd quarter, according to the company in its...
MarketBeat·21h ago
News Placeholder
Migdal Insurance & Financial Holdings Ltd. Makes New Investment in Gilead Sciences, Inc. $GILD
Migdal Insurance & Financial Holdings Ltd. acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with...
MarketBeat·21h ago
News Placeholder
30 Ways Trump Impacted The World In His First Year
30 Ways Trump Impacted The World In His First Year Authored by Travis Gillmore and Cathy He via The Epoch Times, President Donald Trump used his first year back in the White House to set the tone for...
Zero Hedge·2d ago
News Placeholder
Gilead Sciences, Inc. $GILD Shares Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 23.0% in the 3rd quarter, according to the company in its most recent...
MarketBeat·2d ago
News Placeholder
Royal Bank Of Canada Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock
Royal Bank Of Canada boosted their price objective on shares of Gilead Sciences from $100.00 to $103.00 and gave the company a "sector perform" rating in a research report on Tuesday...
MarketBeat·2d ago
<
1
2
...
>

Latest GILD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.